N. J. Lawrence et al. / Tetrahedron Letters 42 (2001) 3939–3941
3941
Table 2. Oxidation of Baylis–Hillman adducts 2 with the
Dess–Martin periodinane
5. Aggarwal, V. K.; Mereu, A. Chem. Commun. 1999, 2311–
2312.
6. Barrett, A. G. M.; Cook, A. S.; Kamimura, A. Chem.
Commun. 1998, 2533–2534.
Ar
R
Yield 2 (%)
Yield 23 (%)
7. Lawrence, N. J.; McGown, A. T.; Nduka, J.; Hadfield, J.
A.; Pritchard, R. G. Bioorg. Med. Chem. Lett. 2001, 11,
429–431.
8. (a) Beekman, A. C.; Woerdenbag, H. J.; van Uden, W.;
Pras, N.; Konings, A. W. T.; Wikstro¨m, H. V.; Schmidt,
T. J. J. Nat. Prod. 1997, 60, 252–257; (b) Picman, A. K.
Biochem. Syst. Ecol. 1986, 14, 255–281; (c) Schmidt, T. J.
Curr. Org. Chem. 1999, 3, 577–608.
a
b
c
d
f
Ph
Ph
Me
Et
Et
Et
Et
See Table 1
See Table 1
See Table 1
See Table 1
86a
84
78
71
67
63
64
51
2-ClC6H4
4-MeC6H4
3,4-F2C6H3
4-FC6H4
4-(CF3)C6H4
g
h
Me
Me
78a
72a
a DABCO™ (0.5 equiv.), ethyl or methyl acrylate (2 equiv.), ArCHO
(1 equiv.), rt (1–7 days) (Ref. 13).
9. (a) Mancuso, A. J.; Swern, D. Synthesis 1981, 165–185; (b)
Tidwell, T. T. Synthesis 1990, 857870; (c) Tidwell, T. T.
Org. React. (NY) 1990, 39, 297–572.
The successful oxidation of Baylis–Hillman adducts has
been achieved by Hoffmann and co-workers17 using
Jones reagent. However we were concerned that trace
toxic chromium-containing residues might possibly com-
plicate the subsequent assessment of the cytotoxicity of
the ketones and sought an alternative reagent. The
Dess–Martin periodinane is often used when a mild,
selective oxidant is required (Table 2).18 Significantly for
us it has been used to effect the synthesis of a-methylene-
cycloalkanones from the corresponding alcohol.19 We
soon found that the reagent met our requirements and
was able to efficiently transform the Baylis–Hillman
adducts into the desired a-methylene-b-keto esters.
Clearly the reaction mixture does not contain a species
sufficiently nucleophilic to react with the product.
10. (a) Cambie, R. C.; Hay, M. P.; Larsen, L.; Rickard, C. E.
F.; Rutledge, P. S.; Woodgate, P. D. Aust. J. Chem. 1991,
44, 821–842; (b) Trost, B. M.; Matelich, M. C. J. Am.
Chem. Soc. 1991, 113, 9007–9009; (c) Bhaskar, K. V.; Chu,
W.-L. A.; Gaskin, P. A.; Mander, L. N.; Murofushi, N.;
Pearce, D. W.; Pharis, R. P.; Takahashi, N.; Yamaguchi,
I. Tetrahedron Lett. 1991, 32, 6203–6206; (d) Castellaro, S.
J.; MacMillan, J.; Willis, C. L. J. Chem. Soc., Perkin Trans.
1 1991, 2999–3004.
11. (a) Atkinson, R. S.; Ulukanli, S.; Williams, P. J. J. Chem.
Soc., Perkin Trans. 1 1999, 2121–2128; (b) Barnhart, R. W.;
Wang, X.; Noheda, P.; Bergens, S. H.; Whelan, J.; Bosnich,
B. J. Am. Chem. Soc. 1994, 116, 1821–1830.
12. Yuasa, Y.; Yuasa, Y.; Tsuruta, H. Aust. J. Chem. 1998, 51,
511–514.
13. Fort, Y.; Berthe, M.-C.; Caube`re, P. Synth. Commun. 1992,
22, 1265–1275.
In conclusion we have shown that Baylis–Hillman
adducts are efficiently oxidized by the Dess–Martin
periodinane but not by DMSO/oxalyl chloride. The
biological activity of the ketones 3 and the unintentional
series of allylic chlorides 4 will be reported in due course.
14. (a) Chavan, S. P.; Ethiraj, K. S.; Kamat, S. K. Tetrahedron
Lett. 1997, 38, 7415–7416; (b) McFadden, H. G.; Harris,
R. L. N.; Jenkins, C. L. D. Aust. J. Chem. 1989, 42,
301–314; (c) Ameer, F.; Drewes, S. E.; Houston-McMillan,
M. S.; Kaye, P. T. J. Chem. Soc., Perkin Trans. 1 1985,
1143–1145.
Acknowledgements
15. Corey, E. J.; Kim, C. U.; Takeda, M. Tetrahedron Lett.
1972, 4339–4342.
16. (a) Hoffmann, H. M. R.; Rabe, J. J. Org. Chem. 1985, 50,
3849–3859; (b) Paquette, L. A.; Bennett, G. D.; Isaac, M.
B.; Chhatriwalla, A. J. Org. Chem. 1998, 63, 1836–1845.
17. Hoffmann, H. M. R.; Gassner, A.; Eggert, U. Chem. Ber.
1991, 124, 2475–2480.
18. (a) Dess, D. B.; Martin, J. C. J. Am. Chem. Soc. 1991, 113,
7277–7287; (b) Boeckman, Jr., R. J. In Encyclopedia of
Reagents for Organic Synthesis; Paquette, L. A., Ed.;
Wiley: New York, 1995; pp. 4982–4987; (c) Boeckman, Jr.,
R. K.; Shao, P.; Mullins, J. J. Org. Synth. 2000, 77,
141–152.
We thank the EPSRC and AstraZeneca (CASE) for a
studentship (to J.P.C.) and for Research Grants (GR/
L52246: NMR spectrometer; GR/L84391: chromato-
graphic equipment) and the Chemical Database Service
at Daresbury.20 We thank the Cancer Research Cam-
paign for additional support.
References
19. (a) Ladlow, M.; Pattenden, G.; Teague, S. J. Tetrahedron
Lett. 1986, 27, 3279–3280; (b) Dupuy, C.; Luche, J. L.
Tetrahedron 1989, 45, 3437–3444; (c) Corey, E. J.; Virgil,
S. C. J. Am. Chem. Soc. 1990, 112, 6429–6431; (d) Bhaskar,
K. V.; Mander, L. N. Tetrahedron Lett. 1996, 37, 719–722;
(e) Stamos, D. P.; Chen, S. S.; Kishi, Y. J. Org. Chem. 1997,
62, 7552–7553; (f) Wong, T.; Wilson, P. D.; Woo, S.; Fallis,
A. G. Tetrahedron Lett. 1997, 38, 7045–7048; (g) Parker,
K. A.; Dermatakis, A. J. Org. Chem. 1997, 62, 6692–6696.
20. Fletcher, D. A.; McMeeking, R. F.; Parkin, D. J. J. Chem.
Inf. Comp. Sci. 1996, 36, 746–749.
1. Baylis, A. B.; Hillman, M. E. D. Ger. Pat. 2,155,113, 1972;
Chem. Abstr. 1972, 77, 34174q.
2. (a) Langer, P. Angew. Chem., Int. Ed. 2000, 39, 3049–3052;
(b) Ciganek, E. Org. React. (NY) 1997, 51, 201–350; (c)
Basavaiah, D.; Rao, P. D.; Hyma, R. S. Tetrahedron 1996,
52, 8001–8062; (d) Drewes, S. E.; Roos, G. H. P. Tetra-
hedron 1988, 44, 4653–4670; (e) Venkatesan, H.; Liotta,
D. C. Chemtracts: Org. Chem. 1998, 11, 29–34.
3. Kawamura, M.; Kobayashi, S. Tetrahedron Lett. 1999, 40,
1539–1542.
4. Rafel, S.; Leahy, J. W. J. Org. Chem. 1997, 62, 1521–1522.